Stock Events

Biomarin Pharmaceutical (BMRN) Q2 2023 Earnings

26AprConfirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
-0.07
0.04
0.16
0.27

Details

Expected EPS
0.21
Actual EPS
0.27
Surprise EPS
0.06
Surprise Percent
+28.57%

Description

Biomarin Pharmaceutical (BMRN) has reported earnings of 0.27 per share for Q2 2023.

0 Comments

Share your thoughts